Cargando…

Recent Drug Development in the Woodchuck Model of Chronic Hepatitis B

Infection with hepatitis B virus (HBV) is responsible for the increasing global hepatitis burden, with an estimated 296 million people being carriers and living with the risk of developing chronic liver disease and cancer. While the current treatment options for chronic hepatitis B (CHB), including...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suresh, Manasa, Menne, Stephan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416195/ https://www.ncbi.nlm.nih.gov/pubmed/36016334 http://dx.doi.org/10.3390/v14081711

Ejemplares similares

Application of the woodchuck animal model for the treatment of hepatitis B virus-induced liver cancer
por: Suresh, Manasa, et al.
Publicado: (2021)

Involvement of Innate Immune Receptors in the Resolution of Acute Hepatitis B in Woodchucks
por: Suresh, Manasa, et al.
Publicado: (2021)

Innate and adaptive immunity associated with resolution of acute woodchuck hepatitis virus infection in adult woodchucks
por: Suresh, Manasa, et al.
Publicado: (2019)

Efficacy of an Inhibitor of Hepatitis B Virus Expression in Combination With Entecavir and Interferon‐α in Woodchucks Chronically Infected With Woodchuck Hepatitis Virus
por: Menne, Stephan, et al.
Publicado: (2020)

Treatment with the Immunomodulator AIC649 in Combination with Entecavir Produces Antiviral Efficacy in the Woodchuck Model of Chronic Hepatitis B
por: Korolowicz, Kyle E., et al.
Publicado: (2021)

Combination Treatment with the Vimentin-Targeting Antibody hzVSF and Tenofovir Suppresses Woodchuck Hepatitis Virus Infection in Woodchucks
por: Korolowicz, Kyle E., et al.
Publicado: (2021)

Antiviral Efficacy and Host Innate Immunity Associated with SB 9200 Treatment in the Woodchuck Model of Chronic Hepatitis B
por: Korolowicz, Kyle E., et al.
Publicado: (2016)

AIC649 Induces a Bi-Phasic Treatment Response in the Woodchuck Model of Chronic Hepatitis B
por: Paulsen, Daniela, et al.
Publicado: (2015)

Toll-Like Receptor 7 Agonist RG7854 Mediates Therapeutic Efficacy and Seroconversion in Woodchucks With Chronic Hepatitis B
por: Wildum, Steffen, et al.
Publicado: (2022)

Toll‐Like Receptor 8 Agonist GS‐9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B
por: Daffis, Stephane, et al.
Publicado: (2020)

The Genome Sequence of the Eastern Woodchuck (Marmota monax) – A Preclinical Animal Model for Chronic Hepatitis B
por: Alioto, Tyler S., et al.
Publicado: (2019)

Liver‐Targeted Toll‐Like Receptor 7 Agonist Combined With Entecavir Promotes a Functional Cure in the Woodchuck Model of Hepatitis B Virus
por: Korolowizc, Kyle E., et al.
Publicado: (2019)

Cryo-EM structures of human hepatitis B and woodchuck hepatitis virus small spherical subviral particles
por: Liu, Haitao, et al.
Publicado: (2022)

Therapeutic Vaccination in Chronic Hepatitis B: Preclinical Studies in the Woodchuck
por: Kosinska, Anna D., et al.
Publicado: (2010)

Agonistic Activation of Cytosolic DNA Sensing Receptors in Woodchuck Hepatocyte Cultures and Liver for Inducing Antiviral Effects
por: Suresh, Manasa, et al.
Publicado: (2021)

Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis B
por: Fletcher, Simon P., et al.
Publicado: (2015)

Correction: Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis B
por: Fletcher, Simon P., et al.
Publicado: (2016)

Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuck
por: Kosinska, Anna D., et al.
Publicado: (2014)

Molecular characterization of woodchuck IFI16 and AIM2 and their expression in woodchucks infected with woodchuck hepatitis virus (WHV)
por: Yan, Qi, et al.
Publicado: (2016)

Enzyme‐altered Liver Cell Foci in Woodchucks Infected with Woodchuck Hepatitis Virus
por: Abe, Kenji, et al.
Publicado: (1988)

Suitability of the woodchuck HCC as a preclinical model for evaluation of intra‐arterial therapies
por: Kim, Alexander Y., et al.
Publicado: (2020)

Antiviral Efficacy and Host Immune Response Induction during Sequential Treatment with SB 9200 Followed by Entecavir in Woodchucks
por: Suresh, Manasa, et al.
Publicado: (2017)

Asymptomatic Hepadnaviral Persistence and Its Consequences in the Woodchuck Model of Occult Hepatitis B Virus Infection
por: Mulrooney-Cousins, Patricia M., et al.
Publicado: (2015)

Prevention of liver tumor formation in woodchucks with established hepatocellular carcinoma by treatment with cationic liposome-DNA complexes
por: Fairman, Jeffery, et al.
Publicado: (2017)

Persistence of the Recombinant Genomes of Woodchuck Hepatitis Virus in the Mouse Model
por: Pan, Danzhen, et al.
Publicado: (2015)

Imaging, Pathology, and Immune Correlates in the Woodchuck Hepatic Tumor Model
por: Mauda-Havakuk, Michal, et al.
Publicado: (2021)

Combination of DNA Prime – Adenovirus Boost Immunization with Entecavir Elicits Sustained Control of Chronic Hepatitis B in the Woodchuck Model
por: Kosinska, Anna D., et al.
Publicado: (2013)

Safety and efficacy of anti-PD-L1 therapy in the woodchuck model of HBV infection
por: Balsitis, Scott, et al.
Publicado: (2018)

Primary Seronegative but Molecularly Evident Hepadnaviral Infection Engages Liver and Induces Hepatocarcinoma in the Woodchuck Model of Hepatitis B
por: Mulrooney-Cousins, Patricia M., et al.
Publicado: (2014)

Diverse Virus and Host-Dependent Mechanisms Influence the Systemic and Intrahepatic Immune Responses in the Woodchuck Model of Hepatitis B
por: Michalak, Tomasz I.
Publicado: (2020)

Initial sites of hepadnavirus integration into host genome in human hepatocytes and in the woodchuck model of hepatitis B-associated hepatocellular carcinoma
por: Chauhan, R, et al.
Publicado: (2017)

The Expression of PD-1 Ligands and Their Involvement in Regulation of T Cell Functions in Acute and Chronic Woodchuck Hepatitis Virus Infection
por: Zhang, Ejuan, et al.
Publicado: (2011)

Immune Effects of Cryoablation in Woodchuck Hepatocellular Carcinoma
por: Mauda-Havakuk, Michal, et al.
Publicado: (2023)

Disturbances in the Glutathione/Ophthalmate Redox Buffer System in the Woodchuck Model of Hepatitis Virus-Induced Hepatocellular Carcinoma
por: Andres Ibarra, Rafael, et al.
Publicado: (2011)

A241 CHARACTERIZING KUPFFER CELL-VIRUS INTERACTIONS IMMEDIATELY FOLLOWING VIRAL INVASION AND IN ACUTE HEPATITIS IN THE WOODCHUCK HEPATITIS VIRUS MODEL OF HEPATITIS B VIRUS INFECTIONS
por: Al-Yasiri, L, et al.
Publicado: (2023)

Differential Expression of Woodchuck Toll-Like Receptors 1–10 in Distinct Forms of Infection and Stages of Hepatitis in Experimental Hepatitis B Virus Infection
por: Williams, John Bradley, et al.
Publicado: (2018)

A novel hepatovirus identified in wild woodchuck Marmota himalayana
por: Yu, Jie-mei, et al.
Publicado: (2016)

Imaging of Tumor-Associated Vascular Prostate-Specific Membrane Antigen in Woodchuck Model of Hepatocellular Carcinoma
por: Sergeeva, Olga, et al.
Publicado: (2022)

Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model
por: Li, Yung-Tsung, et al.
Publicado: (2016)

Inclusion of the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances AAV2-Driven Transduction of Mouse and Human Retina
por: Patrício, Maria I., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_23v82i3c70jqs3o3dr6d1sq37b